Evaluation of P-gp on the transport of antofloxacin by using Caco-2 cell monolayer model

Ke-hua Shao,Chao Jia,Xiu-li Zhao,Min-ji Wei
DOI: https://doi.org/10.13461/j.cnki.cja.004808
2011-01-01
Abstract:Objective To evaluate the effect of P-gp inhibitor ketoconazole on the transport of antofloxacin by using human colon adenocarcinoma line Caco-2 cell monolayer model. Methods The concentrations of antofloxacin collected from the transport assay were determined by high performance liquid chromatography and the transport parameters such as apparent permeability coefficient[Papp (A-B) and Papp (B-A)] and the ratio of Papp (B-A) versus Papp (A-B) were calculated and compared when the antofloxacin was used sololy and co-used with ketoconazole. Results When ketoconazole was present, the Papp (B-A)/Papp (A-B) of antofloxacin decreased from 4.12 to 1.23 and 3.54 to 1.22 at the concentration of 100μmol/L and 500μmol/L, respectively. And Papp (B-A) were also decreased obviously at each concentration level, from 4.23±0.27 to 2.39±0.70 and 8.49±0.89 to 5.03±1.20. Conclusion The reasults indicated that active transport might play a major role in the transport of antofloxacin in Caco-2 cell monolayer model and P-gp involved in the secretion of antofloxacin from basolateral to apical.
What problem does this paper attempt to address?